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Abstract 
Background: Retinopathy of Prematurity is aberrant developmental retinal Angiogenesis in preterm infants. 
For ophthalmologist diagnosis and management of this progressive disease remains a challenge. Objective: To 
investigate the retinopathy of prematurity in premature infants referred to the Eye Clinic of Ayatollah Rouhani 
Hospital in Babol in 2016. Methods: In this cross-sectional study, data on premature infants including risk factors 
for retinopathy and eye examinations were recorded and data were analyzed using Chi-square, single, and multiple 
logistic regression. Results: Among 100 premature infants with mean gestational age, 31. 83 (GA) weeks (2. 06SD) 
and birth weight 1686. 9 (g) (416. 4SD), retinopathy was 39% and severe in 14% of all specimens. In single-
variable analysis, there was a significant relationship between Retinopathy of Prematurity and birth weight, 
gestational age, duration of oxygen therapy, duration of hospitalization and sepsis, while in multivariate logistic 
regression, birth weight and respiratory distress syndrome were independent predictors of retinopathy. 25 cases 
(64. 1%) had spontaneous regression and in 14 cases (35. 8%) treatment was required. The prognosis of treatment 
was desirable in all 14 cases. Conclusion: Timely screening and treatment in infants with severe retinopathy is very 
important in preventing progression of the disease to higher stages and poor vision prognosis.  
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Introduction 
Retinopathy of Prematurity (ROP) is a vascular 
disorder that occurs in premature infant whose retinas is 
not yet fully vascularized. This disease occurs due to 
the occurrence of a damaging agent in the course of 
completing retinal vascularization, which can lead to 
the appearance of fibro-vascular tissue and its 
penetration into the vitreous and eventually blindness 
of the baby (1). Prevention of blindness in children 
under the age of one is the World Health Organization's 
plans by 2020 (2). Retinopathy is one of the potentially 
preventable causes of blindness in children and is 
responsible for 50,000childhood blindness each year 
(3,4). Retinopathy of Prematurity is one of the most 
important causes of blindness in countries where the 
mortality rate for children under the age of one is 10-60 
per 1000 live births (5). The disease, if promptly 
diagnosed, provides a good response to treatment, but 
delay in diagnosis and treatment shortly leads to 
blindness, various methods for the classification, 
diagnosis and treatment of ROP are provided (6). In 
recent years, with the increase in the survival of very 
low birth weight infants (VLBW) due to the 
progression of the NICU, the proportion of high-risk 
infants has increased for the development of ROP (7). 
The most important risk factors associated with ROP are 
low gestational age (GA) and low birth weight (BW) 
(8), so that the ROP is inversely proportional to 
gestational age birth weight (9). Other factors include 
sepsis, oxygen uptake, NICU hospitalization time, 
exposure to steroids, and mechanical ventilation for 
more than 7 days, exchange of blood and receiving 
surfactant (10, 11, and 12).  
In a recent study, in 70%infants with a birth 
weight of less than 1250 g and advanced ROP, 
treatment for severe type of disease was needed in only 
6% of cases (13). In premature infants, the growth and 
development of retinal blood vessels is not yet 
completely understood. Perhaps the pathogenesis of 
ROP is that prematurity interferes with the process of 
natural retinal vascularization. Retinal growth in 
postnatal period occurs in an unstable and high-oxygen 
environment, and the effect of hypoxia-induced 
stimulation on the development of retinal vascular 
system decreases. The result is delayed vascularization 
of the retina, which ultimately leads to abnormal vessels 
and neovascularization. The problem with abnormal 
blood vessels is that they do not give enough oxygen to 
the retina. Retinopathy is divided into 5 stages and 3 
zones. The progression of the disease to the last degree 
can cause retinal complications, such as retinal 
detachment, vitreous hemorrhage, and blindness.  
The likelihood of survival in premature infants 
has increased in recent years in countries such as Iran, 
with an increase in the general level of health and 
treatment and a reduction in the mortality rate of infants, 
and it is expected that Iran is one of the countries  that is 
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at high risk of severe visual impairment caused by ROP 
(14). Although a large group of infants with ROP 
undergo spontaneous regression without any 
complications, approximately 6% of low-birth weight 
infants (less than 1251 g) require advanced treatment for 
severe ROP. Despite the advances in prevention, 
detection and treatment of ROP in the world, 
complications such as cataracts, glaucoma and 
amblyopia have increased the complexity of the 
problem. Considering the importance of early diagnosis 
and treatment of ROP optimal vision prognosis in infants 
develops, in this study, we examined the ROP course 
and the prognosis of treatment.  
 
Preventive retinopathy screening 
Evaluation of the screening program involves 
performing a complete eye examination by a qualified 
ophthalmologist in neonatal ophthalmology. The pupils 
should be dilated to see the vitreous and retina. It is 
recommended that droplets containing low 
phenylephrine and Cyclopentolate concentrations be 
used 30 minutes before the eye examination with 
binocular indirect ophthalmoscope using 28D lens by 
expertise ophthalmologist (15). Using eye drops for 
pupillary dilation and eye manipulation can cause 
systemic complications for the baby, most of all are 
bradycardia and cardiac arrhythmia. Therefore, accurate 
monitoring of the baby is essential during the 
examination. An examiner can also use topical 
anesthetics (16). Initial screening tests are performed 4 
to 6 weeks after birth. Compared to GA, for infants born 
at 22-26 weeks of gestation, initial examinations are 
performed at week 30 and for babies born at weeks 27 or 
over at 4 weeks postnatal. This program meets the 
criteria for screening in developed countries for infants 
weighing less than or equal to 1250 g or a gestational 
age of less than 31 weeks, obtained using 2 randomized 
trials (17, 18).  
 
Research Questions 
What are the factors influencing the incidence of 
ROP? 
How many of the studied samples progress to the 
higher stages of the disease? 
 
Methodology 
The present study was conducted to investigate 
the retinopathy of prematurity in premature infants 
referred to the Eye Clinic of Ayatollah Rouhani Hospital 
in Babol in 2016. The study was a cross-sectional study. 
The target population included all premature infants 
referred to the NICU department (north of the Iran). The 
sample population was selected from the target 
community with the requirement to enter the study. 
Thus, by examining the case records of the infants, the 
following two groups were studied as target society: 
1- Preterm infants with gestational age less than 32 
weeks or birth weight less than 1500 grams 
discharged from the NICU even though they have not 
received treatment with oxygen.  
2- Premature infants between 1500-2500 grams or more 
than 32 weeks have an unstable clinical course and 
are admitted to the NICU.  
After considering the conditions of entry and exit, 
106 newborns were enrolled in the study, of which were 
excluded five newborns were excluded due to lack of 
referral after the initial examination and one newborn 
due to lack of referral for treatment follow-up treatment 
was with 0/675mg Avastin injected intravitreally. 
Finally 100 newborns were examined and followed up. 
Sampling method was simple non-random. The patient 
information summary is extracted and entered in the 
questionnaire that is included. This information includes 
gestational age, birth weight, gender, oxygen therapy, 
type of oxygen therapy, hospitalization period, oxygen 
therapy period, and underlying disease. Four quadrants 
of each of the two eyes were subjected to precise 
examination, and then the stage and zone were recorded 
according to the international classification of 
Retinopathy of Prematurity (ICROP) in the 
questionnaire form. Follow-up examinations were 
performed every 2-3 weeks, once a week or twice 
weekly, in infants weighing less than 1000 grams or 
premature infants with active obesity retinopathy. In the 
case of retinopathy, THRESHOLD ROP(T-ROP) was 
immediately treated in less than 72 hours and follow-up 
examinations were carried out once a week in the first 
month, then every month (depending on the severity of 
the disease) to determine the prognosis of the treatment.  
All information was entered into SPSS software 
version 15 and then analyzed. Descriptive statistical 
methods such as Frequency and Descriptive for 
examining the percentage of frequency of clinical and 
preclinical manifestations, chi-square test was used for 
analyzing qualitative variables and t-test was used for 
analyzing the quantitative variables and the logistic 
regression test was used to determine the relationship 
between variables with pre-term retinopathy.  
 
Findings 
In the study of premature infants referred to the 
NICU section of different treatment centers (north of 
Iran) in the Eye Clinic of Ayatollah Rouhani Hospital in 
Babol in 2016, the findings and the following results 
were obtained: 
Of the 100 infants, 58 infants (58%) were male 
and 42 infants (42%) were female. The mean gestational 
age of the subjects (GA) was 31. 83±2. 06 weeks, with a 
minimum of 26 and a maximum of 36 weeks. The mean 
birth weight (BW) of the study group was 1686. 9±416. 
47 grams, which weighed at least 630grams and a 
maximum of 2700 grams. 79 infants were treated with 
supplemental oxygen; among which oxy hood (53%) 
was the most commonly used method for supplemental 
oxygen therapy. The mean duration of oxygen therapy 
was 4. 5±4. 6 days. The mean hospitalization time was 
18. 75±13. 76 with a minimum of 2 and a maximum of 
90 days.  
ROP was confirmed in 39% of the samples, of 
which 14 (35. 8%) had therapy after the first 
examination (T–ROP). Of the cases with retinopathy, 8 
cases (20. 5%) had Stage 1 disease, 17 cases (43. 5%) 
had Stage 2 disease, and 14 cases (36%) had Stage 3 
disease. In the zone involved, 25 cases (25%) of the 
zone 1 and 14 (14%) were affected by zone 2 disease, 
and in no case retinopathy occurred in zone 3. The 
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highest prevalence of ROP was in the range of 29-32 
weeks of gestational age (GA). ROP was seen in 29 
cases of less than or equal to 32 weeks, and in 10 cases 
more than 32 weeks old. The relationship between ROP 
and gestational age (GA) is presented in Table 1.  
 
Table 1. Relationship between ROP with GA  
 
17 cases of 39 infants with ROP (43. 5%) had a 
birth weight of less than 1500 grams. The relationship of 
ROP with birth weight (BW) is presented in Table 2.  
 
Table2. Relationship between ROP with BW 
 
 
In the study of correlation of variables with ROP 
using the single-variable logistic regression model, the 
following results were obtained: based on the findings, 
the age of less than 32 weeks (OR=2. 91, P-value=0. 
017), birth weight (BW) less than 1500 grams (OR=3. 
512, P-value=0. 007) and sepsis (OR=2. 88, P-value=0. 
046) were significantly associated with ROP. Six infants 
from the study group underwent blood transfusion, 2 of 
them had no ROP, and 4infants had ROP, which did not 
show any significant correlation between blood 
transfusion and ROP. (P-value=0. 20)The mean duration 
of oxygen therapy in with retinopathy group was 6. 1±5. 
7 and in without retinopathy group was 3. 48±3. 36 
days, which had a significant correlation with ROP. (P-
value=0. 012). The mean duration of admission in with 
retinopathy group was 24. 59±17. 01 and in without 
retinopathy group was 15. 02±9. 63 days, which was 
related to ROP (P-value = 0. 002).  
 
Discussion and Conclusion 
In this study, from 100 samples with a mean GA 
of 31. 83±2. 06 weeks and a mean BW of 1686. 9±416. 
46 grams, Retinopathy of Prematurity was observed in 
39% of cases. Severe ROP types require treatment in 14 
infants from 39 preterm infants with retinopathy (35. 
8%). Among cases with retinopathy, 20. 5% were at 
stage1, 43. 5% at stage2 and 36% at stage3 disease.  
Mousavi et al. , during the years 2003-2007, with 
a study of 1053 premature infants who referred to Farabi 
Hospital in Tehran, reported an ROP of 36. 1% (19). 
Karkhaneh et al. , also conducted a study on 953 
premature infants in Tehran from 2003 to 2007, with an 
overall prevalence of ROP of 34. 4% and a severe type 
Total 
(N) 
Without 
ROP 
N )%( 
With ROP 
N )%( 
Gestational 
age 
(GA) 
7% 2 (2%) 5 (5%) 25-28 
55% 31 (31%) 24 (24%) 29-32 
38% 28 (28%) 10 (10%) >32 
Total 
(N) 
Without 
ROP 
N )%( 
With ROP 
N )%( 
Weight 
7% 1% 6% 500-1000 
29% 16% 13% 1001-1500 
43% 30% 13% 1501-2000 
21% 14% 7% >2000 
of ROP 22. 6% (20).  
Multu et al. , in Turkey, evaluated 314 premature 
infants with GA (less than 34 weeks), the prevalence of 
ROP was 37. 1%, of which 7. 2% were at stage 3 or 
above, in 16. 1% of cases, treatment for premature 
retinopathy was required (21). The results of these 
studies were similar to those of the present study in 
terms of prevalence of ROP.  
In a survey conducted in New York by Chiang et 
al. during the years 1996-2000, among 1167427 
premature infants, 0. 2% or 1 in 511 infants suffered 
from ROP and about 9. 5% of the samples were treated 
with laser (22). Larsson reported a general outbreak of 
ROP 25. 5% in a study in infants less than 32 weeks of 
gestational age during 1998-2000(23). Ahmed, in 
Bangladesh, with a study of 114 infants during the years 
1998-2003, reported an ROP of 4. 4% (24). In the study 
of Shah et al in Singapore, among 564 premature 
infants,29. 2% of cases had premature retinopathy, 49% 
had stage 1 disease, 24% had stage 2 and 7% had stage 
3 or higher, and 62. 2% had need of treatment (25).  
According to studies, this wide difference in the 
prevalence of ROP in various studies in different 
countries is probably due to the difference in the rate of 
progression of the NICU and, consequently, the survival 
of infants with birth weight and gestational age (Using 
pre-natal steroid injections to mother as well as 
surfactant prophylaxis for the development of neonate 
lung maturity). Considering that low birth weight and 
low gestational age are the most important risk factors 
for retinopathy, the best way to prevent the 
development of ROP is to prevent premature infant 
births, but reducing risk factors along with this problem 
is effective in reducing its incidence. With the proper 
management of oxygen therapy, the control of 
infections in the NICU segment to prevent sepsis and 
control other risk factors can reduce the incidence of 
retinopathy. Therefore, the treatment teams need to pay 
more attention to these issues.  
In a study of 39 infants with preterm retinopathy, 
14 infants had severe ROP types requiring therapy. All 
14 infants with severe ROP underwent intravitreal 
injection, with good visual prognosis in all 14 cases, 
and no case needed to be re-treated, also, none of the 
samples progressed to the higher stages of the disease. 
25 infants with mild ROP from 39 infants with 
retinopathy (64. 1%) had spontaneous regression 
without need for treatment. Based on the present study, 
the prevalence of retinopathy is high, which can be 
indicative of the improvement of NICU and the survival 
of premature infants (birth weight and low gestational 
age). Also, preventing the birth of a premature infant 
and correcting oxygen therapy is a major contributor to 
Retinopathy of Prematurity and the optimal prognosis 
after treatment indicates the importance of timely 
diagnosis and treatment of ROP, which delay in 
examinations after the 6th week of birth and delayed 
treatment, can have serious consequences for the sight 
of the infant. Therefore, considering the risk of 
premature infants, routine screening for all NICU 
sections of the infant is recommended.  
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Suggestions 
One of the research limitations is the difficulty of 
conducting examinations in preterm infants due to the 
lack of co-operation of the patients during the 
examination, full pupil dilation and examination of all 
parts of the retina, in particular the prefill part, for 
examination of vascularization, as well as the lack of 
regular referral of patients due to the lack of awareness 
of their families about the importance of conducting 
regular and sequential examinations to determine 
progression or improvement of the disease. The 
following suggestions are made to make work better: 
Design a specific screening plan for physicians 
and staff members of the premature infants who do not 
have enough knowledge in this area.  
The Ministry of Health's Healthcare Program 
requires more support by raising the level of public 
awareness and NICU staff.  
If the infant is at risk and the family is not 
suitable, conditions will be created to inform the infant 
by the hospital staff to the relevant centers.  
The need for parents to know about retinopathy.  
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